within Pharmacolibrary.Drugs.ATC.L;

model L01XX59
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.57,
    Cl             = 80.9 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.055799999999999995,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00055,
    Tlag           = 2820
  );

  annotation(Documentation(
    info ="<html><body><p>Enasidenib is an oral, selective inhibitor of isocitrate dehydrogenase 2 (IDH2), used primarily in the treatment of relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. It is approved by the FDA and is currently used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients (female and male) with relapsed or refractory AML following oral administration.</p><h4>References</h4><ol><li><p>Stein, EM, et al., &amp; Tallman, MS (2017). Enasidenib in mutant . <i>Blood</i> 130(6) 722–731. DOI:<a href=&quot;https://doi.org/10.1182/blood-2017-04-779405&quot;>10.1182/blood-2017-04-779405</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28588020/&quot;>https://pubmed.ncbi.nlm.nih.gov/28588020</a></p></li><li><p>Li, Y, et al., &amp; Zhou, S (2018). Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects. <i>Pharmacology research &amp; perspectives</i> 6(6) e00436–None. DOI:<a href=&quot;https://doi.org/10.1002/prp2.436&quot;>10.1002/prp2.436</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30386625/&quot;>https://pubmed.ncbi.nlm.nih.gov/30386625</a></p></li><li><p>Del Principe, MI, et al., &amp; Venditti, A (2019). An evaluation of enasidenib for the treatment of acute myeloid leukemia. <i>Expert opinion on pharmacotherapy</i> 20(16) 1935–1942. DOI:<a href=&quot;https://doi.org/10.1080/14656566.2019.1654456&quot;>10.1080/14656566.2019.1654456</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31454277/&quot;>https://pubmed.ncbi.nlm.nih.gov/31454277</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01XX59;
